November 28, 2022

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Registration is now open for the NRG Oncology Winter 2023 Meeting to be held both in Orlando and virtually, January 26-28, 2023.

Click here to register today!

(Registrations after January 3^rd will incur a late registration fee)

Now accepting applications for travel awards - NRG 2023 winter meeting

All travel award applications have been consolidated into one form. All applications must be received by December 2, 2022. Awardees will be notified by December 9, 2022. Please be sure to attach any required materials, when applicable, to complete your application. 

The available award categories are NRG NCORP Award (2 Awards), NRG Early Career & New Investigators Travel Award, and the Machtay Young Investigators Award. More information regarding each award category is available on our NRG Oncology website in the NRG 2023 Meeting webpages. If you have any questions regarding travel awards, please reach out to meeting-reg@nrgoncology.org.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Actively Recruiting MALE Patients only. Read More

2. GYNECOLOGIC

GOG-0210: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

GOG-0225: To provide the most accurate and reliable assessment possible, sites are asked to answer any outstanding queries and update the Overall Survival status and last contact date for all patients enrolled on GOG-0225 no later than Friday, December 2, 2022. This trial utilizes the SEDES EDC system for form entry. If site personnel need access to SEDES for this study, please contact support@nrgoncology.org. SEDES can be accessed via the GOG Web menu.

NRG-CC008: Spanish translated consent form is now available on CTSU.

NRG-GY012 and NRG-GY023 – BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation.  

3. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, December 14, 2022.

DRUG SAFETY UPDATES

Drug Safety updates have been issued for the following studies:

NRG Mentorship Working Group Update

Are you a new CRA or CTN within NRG Oncology? Would you like a mentor to help guide you through your new role as a CRA or CTN? Are you an institution in need of more guidance after an audit? The Mentorship Working Group can provide you a mentor! You can apply for a mentor by going to the NRG Oncology website and clicking on the Clinical Trials tab, then Clinical Trials Resources, then Introductory Materials. You will find the Mentor Form to complete. The instructions on how to submit are located on the form. Hope to hear from you soon!

Biospecimen Bank San Francisco Shipping Update

Due to an ongoing strike by some employees at the University of California, the NRG Oncology Biospecimen Bank San Francisco located at UCSF is requesting sites to use Fed Ex for all shipments to the bank until further notice. UPS deliveries to the San Francisco bank cannot be guaranteed during the strike. Please use Federal Express for specimen shipments or delay non-urgent shipments at this time. Please contact the lab at NRGBB@UCSF.EDU prior to resuming shipping by UPS for an update after Thanksgiving.

PUBLICATIONS REMINDERS

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ; OlympiA Clinical Trial Steering Committee and Investigators. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. Ann Oncol. 2022 Oct 10:S0923-7534(22)04165-5. doi: 10.1016/j.annonc.2022.09.159. Epub ahead of print. PMID: 36228963. Read more

Henry NL, Kim S, Hays RD, Diniz MA, Tighiouart M, Gresham G, Luu M, Cecchini RS, Yothers G, Rogatko A, Ganz PA. Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30. NPJ Breast Cancer. 2022 Nov 19;8(1):123. doi: 10.1038/s41523-022-00489-9. PMID: 36402796. Read more

Korpics MC, Katipally RR, Partouche J, Cutright D, Pointer KB, Bestvina CM, Luke JJ, Pitroda SP, Dignam JJ, Chmura SJ, Juloori A. Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):645-654. doi: 10.1016/j.ijrobp.2022.06.068. Epub 2022 Jun 23. PMID: 35753553. Read more

Please note the following upcoming meeting and abstract submission deadline dates

UPCOMING MEETINGS

American Society of Clinical Oncology (ASCO) GI; Jan 19-21, 2023; San Francisco, CA

San Antonio Breast Cancer Symposium (SABCS); Dec 6-10, 2022; San Antonio, TX

Society of Urologic Oncology (SUO); Nov 30-Dec 2, 2022; San Diego, CA

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association for Cancer Research (AACR); Apr 14-19, 2023; Orlando, FL; LBA Jan 12, 2023

American Head & Neck Society (AHNS); July 8-12, 2023; Montreal, QC Canada; meeting submission deadline Jan 24, 2023; meeting submission deadline Feb 14, 2023; LBA Mar 16, 2023, Noon (EST)

American Society of Clinical Oncology (ASCO); Jun 2-6, 2023; Chicago, IL; due to publications committee Jan 24, 2023; meeting submission deadline Feb 14, 2023, 1159 pm EST; LBA Mar 16, 2023, Noon (EST)

American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium; Feb 16-18, 2023; San Francisco, CA; LBA Dec 13, 2022, Noon (EST)

ESMO Gynaecological Cancers Annual Congress 2023; Feb 23-24, 2023; Barcelona, Spain; meeting submission deadline Nov 29, 2022, TIP 9 pm CET (CntEurTime)

European Society for Radiotherapy and Oncology (ESTRO); May 12-16, 2023; Vienna, Austria; LBA Jan 18, 2023, 9 pm EST

Society of Surgical Oncology (SSO 2023); Surgical Cancer Care; Mar 22-25, 2023; Boston, MA; LBA Dec 9, 2022

St. Gallen Breast Cancer Conference (SG-BCC); Mar 15-18, 2023; Vienna, Austria; due to publications committee Dec 2, 2022; meeting sub meeting submission deadline Feb 14, 2023, 1159 pm EST; LBA Mar 16, 2023, Noon